CHIRLOYO
Live / Applied — Non-final action mailed (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 18 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79448562
- Mark type
- Stylized text
- Filed
- 18 Mar 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical preparations, namely for treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); pharmaceutical preparations, namely for treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia; medical preparations for the treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia.
- Class 010 — Medical apparatus: Devices for introducing pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS), and parts and fittings therefor; devices for introducing pharmaceutical preparations, namely for treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia, and parts and fittings therefor.
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical services, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical advice, namely in relation to treatment or prevention of stomach and bowel-related disorders and gastrointestinal diseases and disorders in humans, such as short bowel syndrome (SBS); medical and pharmaceutical services, namely in relation to treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia; medical and pharmaceutical advice, namely in relation to treatment of human patients suffering from CHI (congenital hyperinsulinism) and/or hypoglycemia.
Owner
Prosecution history
- 09 Sept 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 09 Sept 2026 — REFUSAL PROCESSED BY MPU
- 26 Jun 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 25 Jun 2026 — NON-FINAL ACTION WRITTEN
- 22 Jun 2026 — ASSIGNED TO EXAMINER
- 23 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Apr 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB